Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.82)
# 3,322
Out of 5,245 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $17.24 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $21.55 | +219.10% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $2.47 | +183.40% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.7313 | +1,951.14% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $1,080 | $1.19 | +90,656.30% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $87.81 | -60.14% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $14.88 | +236.11% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $0.8165 | +186,060.44% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $9.21 | +1,040.07% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $52.47 | -44.73% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.02 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $17.24
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $21.55
Upside: +219.10%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $2.47
Upside: +183.40%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.7313
Upside: +1,951.14%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $1,080
Current: $1.19
Upside: +90,656.30%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $87.81
Upside: -60.14%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $14.88
Upside: +236.11%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $0.8165
Upside: +186,060.44%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $9.21
Upside: +1,040.07%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $52.47
Upside: -44.73%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.02
Upside: -